share_log

公告精选 | 歌礼制药新冠口服药获积极I期临床结果;海吉亚医疗拟收购二甲医院股权

Selected Announcements | Geli Pharmaceutical's COVID-19 Oral Drug Receives Positive Phase I Clinical Results; Hygia Healthcare Plans to Acquire Shares in Second Class Hospitals

Futu News ·  Dec 13, 2022 08:13

Selection of blockbuster announcements

1. Hagia Medical: intends to acquire no less than 70% stake in second-class first-class general hospitals in the Yangtze River Delta.

$Hygeia Healthcare Holdings (06078.HK)$In an announcement, on December 12, 2022, the company entered into a non-legally binding letter of intent with a potential seller, under which the company and ╱ or its designated subsidiaries may agree to purchase in the form of capital increase or equity transfer, while the potential seller may agree to sell no less than 70 per cent of the shares in the target hospital. The target hospital is a second-class first-class general hospital located in the Yangtze River Delta.

2. Goliath Pharmaceuticals-B: COVID-19 oral RdRp inhibitor ASC10 achieved positive phase I clinical results.

$ASCLETIS-B (01672.HK)$COVID-19 's multi-dose incremental (MAD) phase I study of COVID-19 's oral polymerase (RdRp) inhibitor ASC10 in healthy subjects obtained positive top-line data. Phase I data showed that all doses of ASC10 were safe and well tolerated in Chinese subjects. Safety data were similar in the ASC10 group and the placebo group.

3. Metro development: the cumulative contract sales in the first 11 months was about 109.5 billion yuan, a decrease of 48.6% compared with the same period last year.

$SEAZEN (01030.HK)$It was announced that the cumulative contract sales from January to November was about 109.481 billion yuan, a decrease of 48.6 percent over the same period last year, and the cumulative sales area was about 11.1701 million square meters. In November, the contract sales amount was about 6.531 billion yuan, a decrease of 67.4% over the same period last year, with a sales area of about 716400 square meters.

4. China Resources Land: the cumulative contract sales in the first 11 months was about 251.73 billion yuan, down 7% from the same period last year.

$CHINA RES LAND (01109.HK)$According to the announcement, in November, the group realized a total contract sales of about 22.2 billion yuan, with a total contract sales area of about 1.0981 million square meters, an annual increase of 9.1% and a decrease of 11.9% respectively. The cumulative contract sales in the first 11 months was about 251.73 billion yuan, with a total contract sales area of about 11.5519 million square meters, an annual decrease of 7.0% and 26.1%, respectively.

The People's Insurance: the original insurance premium income in 11 months was about 571.4 billion yuan, an increase of 7.57% over the same period last year.

$PICC GROUP (01339.HK)$It was announced that from January to November, the original insurance premiums earned through PICC property insurance, PICC life insurance and PICC health insurance were 442.677 billion yuan, 88.675 billion yuan and 40.026 billion yuan respectively, totaling 571.378 billion yuan, an increase of 7.57 percent over the same period last year.

6. R & F Real Estate: no bond has been provided for tension bail and the case will not have a significant adverse impact on our company.

$R&F PROPERTIES (02777.HK)$According to the notice, the company is aware of media reports about a court case in the United States in the United States concerning Zhuan L Properties Inc. The pending case granted bail to Mr. Zhang, a director of the company. The Company clarified that it did not provide any bond for bail, and that it did not provide any security for bail in Zagrel Properties Inc. There is no interest (owned by Mr. Zhang and his related parties) and the case will not have any material adverse impact on the business and operations of the Company.

Listing of new shares

The Hong Kong offering shares of Midea Group (01947) were 41.31 times oversubscribed and the final offering price was HK $0.84 per share.

Dacheng shares (01405) will be offered at a price of HK $46-50 per share since December 13th.

Ke Ju Medical (06929) launched its initial public offering on December 13 at a price of HK $8.80 per share.

Operation data

Metro Development (01030) the cumulative contract sales from January to November is about 109.481 billion yuan

China Resources Land (01109): the cumulative contract sales in the first 11 months were about 251.73 billion yuan, down 7% from the same period last year.

New China Life Insurance (01336): the original premium income from January to November was 156.751 billion yuan, an increase of 1.06% over the same period last year.

PICC Property and Casualty (02328) the original premium income from January to November totaled 442.677 billion yuan, an increase of 9.2% over the same period last year.

The People's Insurance's original insurance premium income in the first 11 months of 01339 was about 571.4 billion yuan, an increase of 7.57% over the same period last year.

Yue Yuen (00551): net consolidated operating income of US $657 million in November

DongFeng Motor Group (00489) sold 307700 new energy vehicles in the first 11 months, an increase of 129.2% over the same period last year.

Increase and decrease holdings

Chen Qiyuan, chairman and controlling shareholder of Sikole Education (01769), increased his holdings of a total of 3.1 million shares

Merger and acquisition and sale

Beijing Energy International (00686) plans to buy all shares of Shengyang New Energy Power Generation in Fengtai County with 452 million yuan.

Shenzhen International (00152) intends to sell 100% stake in Hangzhou Shenzhen International supply chain Management

Geely Automobile (00175) subsidiary plans to acquire all shares of Xi'an Geely for 382 million yuan.

China Agricultural Ecology (08166) subsidiary signed a strategic cooperation agreement with Sichuan Dufu Wine Group.

Additional rights issue

Easy Life Holdings (00223) proposes a discount of about 19.6% to place up to 150 million net shares of HK $19.6 million.

ITP HOLDINGS (08446) plans to issue 13.1579 million additional shares to ST MA with a net raise of HK $59 million

Important matters

Golly Pharmaceutical-B (01672): COVID-19 achieved positive phase I clinical results by oral administration of RdRp inhibitor ASC10.

COSCO Shipping Holdings (01919) plans to buy 100% equity of Hai Zhen Blue with 1.191 billion yuan.

Hagia Medical (06078) intends to acquire no less than 70% stake in second-class first-class general hospitals in the Yangtze River Delta.

Zhengrong Real Estate (06158): the Group has received some support in terms of housing mortgage loans and domestic financing extension.

China Software International (00354) and Railway Construction heavy Industry sign Hongmeng Lianchuang Cooperation Agreement

Lizhu Pharmaceutical (01513) and Health Yuan terminate the partnership agreement and form a joint venture in the form of cash investment

Drug Gunuo-B (02126): the latest clinical data of Benoda ®for follicular lymphoma and mantle cell lymphoma were presented at the 64th annual meeting of the American Hematological Society.

Feitian Yun Motion (06610) spent about HK $140 million to buy 31.426 million Yichen shares

R & F Real Estate (02777): no bond has been provided for tension bail and the case will not have a significant adverse impact on our company.

Repurchase cancellation

Tencent (00700) spent HK $350 million to buy back 1.1 million shares on December 12.

Great Wall Motor (02333) spent HK $305 million to buy back 29.452 million shares on December 12.

AIA Group Limited (01299) spent HK $224 million to buy back 2.634 million shares on December 12.

Bailongyun-W (06608) spent HK $3.671 million to buy back 346000 shares on December 12

Yongda Motor (03669) spent HK $5.61 million to buy back 1 million shares on December 12.

XIAOMI Group-W (01810) spent HK $24.48 million to buy back 2.2 million shares on December 12th

Haier Smart Home (06690) spent HK $13.1448 million to buy back 500000 shares on December 12.

Equity incentive

CTS (00308) proposes to adopt a new share option scheme

Edit / somer

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment